A subscription to JoVE is required to view this content. Sign in or start your free trial.
Not Published
To maximize the potential benefits of pulmonary gene therapy, widespread and uniform topical delivery of a viral vector across the surface epithelium is an important goal. Here, we demonstrate an aerosolization technique using a microsprayer positioned intratracheally to deliver a viral vector to newborn pig airways.
Gene therapy for airway diseases requires efficient delivery of nucleic acids to the intrapulmonary airways. In small animal models such as mice, gene delivery reagents are commonly delivered as a bolus dose. Routes of delivery may include either nasal sniffing or direct tracheal instillation. However, using a large animal model for preclinical applications is relevant for translation to human trials. Widespread and uniform distribution of transgene expression is critical for developing a successful lung gene therapy treatment. Aerosolizing viral vectors to the lungs of large animals, such as pigs or sheep, is a strategy to maximize gene transfer efficiency and results in greater airway distribution than a liquid bolus dose. Here we demonstrate a technique for direct aerosolization of a viral vector to the airways of newborn pigs. Briefly, a pig is anesthetized, intubated with an endotracheal tube, and a microsprayer is passed through the endotracheal tube. A syringe is used to push the vector through the microsprayer, resulting in a fine mist being released into the distal trachea. The microsprayer produces ~15-16 μm size particles that deposit across the proximal and distal regions of the lung. Using a microsprayer to deliver an adenoviral-based vector, we previously observed ~30-50% of surface epithelial cells transduced in both the large and small airways of newborn pigs.
Gene transfer to the lung holds great potential for treating many genetic diseases, such as cystic fibrosis or alpha-1 antitrypsin deficiency. However, developing gene therapy approaches to successfully deliver genes of interest to the airways has been challenging. Animal models play a major role in driving innovation of viral vector design and delivery strategies to the intrapulmonary airways. Indeed, we and others have developed methods to overcome many gene delivery hurdles using large animal models. Many examples of delivery challenges have been previously reviewed1,2,3,4,5. Using pigs as a large animal model, we have refined a protocol to achieve widespread airway distribution following intratracheal aerosol delivery.
Here we demonstrate how to achieve efficient viral vector delivery to a pig lung through aerosolization. Conceptually, topical delivery of a vector encoding a therapeutic transgene to the lung is simple. However, in practice, achieving efficient delivery is a challenge. Important considerations include the viral vector, the appropriate vehicle for the vector, and the aerosolization method. In general, devices for generating airborne vectors can be categorized as follows: aerosolizing catheters, atomizers, and nebulizers. All devices convert liquids into particles small enough for respiration. Aerosolizing catheters convert liquids into particles at expulsion. For these studies, we use a syringe-mounted aerosolizing catheter named a microsprayer. We selected a microsprayer as our aerosolization device in part because of its ease of use and because of its ability to effectively aerosolize a viral vector in a particle size that can reach all areas of the lung. We quantified droplet geometric size by laser diffraction and obtained consistent measurements of 15-16 µm for each droplet. The microsprayer works by generating an aerosol at its tip that results from the force generated by depressing a syringe plunger. We validated this delivery method for both adenoviral (Ad)- and adeno-associated virus (AAV)-based viral vectors6,7.
Alternatively, there are aerosolizing catheter devices that utilize pressurized delivery through compressed air. Particle sizes as small as 4-8 µm may be possible with pressurized delivery. Such a device was used to aerosolize helper-dependent adenovirus vectors to rabbit airways8,9 and Sendai virus vectors to sheep10. Atomizers are a type of aerosolizing catheters that deliver large sized particles (~30-90 µm diameter). We have observed that this type of atomizer is effective for delivering multiple viral vectors, including lentiviral vectors, especially when formulated with a viscoelastic material such as methylcellulose11. Nebulizers first convert the liquid into a mist that is passively inhaled. Using this strategy, a plasmid-based vector was delivered to the airways of CF patients in a phase IIB gene therapy trial12. Nebulization requires a large volume of concentrated material and is therefore the least economical option for delivery of viral vectors.
Prior to developing this protocol, we tested multiple different delivery methods in newborn pigs. We evaluated localized delivery via a pediatric bronchoscope lined with either a PE20 catheter delivered as a bolus liquid dose, or through a drug infusion balloon13. Additionally, we tested an atomizer14 and a pressurized aerosolizing catheter (unpublished). The pressurized aerosolizing catheter delivery was effective but required extra equipment and the pressurized delivery occasionally resulted in injury to pig tracheas. Based on ease of use and reproducibility, we now routinely opt for the syringe-mounted microsprayer for delivery of encapsidated viral vectors such as adenoviral and adeno-associated viral vectors. The atomizer gives the most comparable lung expression to the microsprayer without needing to pass through an endotracheal tube. Although our focus has been on developing a delivery method for efficient lung gene transfer to correct cystic fibrosis, this method could be adapted for other applications. The aerosolization device and droplet size may play an important role in the efficiency and distribution of vector mediated transgene expression. Here, we focus on the procedure of intubation in newborn pigs and passing an aerosolizing catheter through an endotracheal (ET) tube to deliver vector.
All animal experiments performed following this protocol must be approved by the respective Institutional Animal Care and Use Committee (IACUC). All procedures described here were approved by the University of Iowa IACUC.
1. Prepare the procedure space and vector delivery materials.
2. Sedate the pigs.
3. Intubate the sedated pigs with an endotracheal tube.
4. Aerosolize the viral vector using the microsprayer.
5. Monitor the pigs as they come out of sedation.
NOTE: Apnea is a common response to intubation in newborn pigs. Sporadic breathing may last 2-3 min. Gentle chest compressions can help facilitate normal breathing.
We previously validated this technique for delivering gene transfer vectors to pig lungs and showed widespread and uniform airway distribution following delivery of an adenoviral vector expressing green fluorescent protein (GFP)6. To assess transduction, all six lung lobes were separated into two to four segments. From each segment, tissue was designated for DNA or mRNA isolation and transduction was quantified by real-time PCR to detect the GFP sequence. GFP-posit...
Widespread airway distribution of a viral vector would help ensure the success of a gene therapy approach for treating pulmonary diseases. Here, we demonstrate an aerosolization technique that leads to whole lung expression of large and small pig airways. We describe the steps for sedating a pig, intubating with an ET tube, and aerosolizing a viral vector through the microsprayer aerosolization device. This technique is important as a preclinical approach to testing viral vector efficacy.
Ther...
The authors have nothing to disclose.
We thank Christian Brommel for aiding with the airway dissection and Raul Villacreses Rada with the supplemental movie. We thank the University of Iowa Office of Animal Resources and the animal caretakers. We thank the Viral Vector Core for vector production. This work was supported by the National Institutes of Health [NIH P01 HL-51670, NIH P01 HL-091842, NIH R01 HL-133089, NIH R01 HL-105821], the Center for Gene Therapy of Cystic Fibrosis [NIH P30 DK-054759], and the Cystic Fibrosis Foundation [SINN19XX0] and [COONEY18F0].
Name | Company | Catalog Number | Comments |
Atomizer | Teleflex | MAD700 | MADgic Laryngo-Tracheal Mucosal Atomization Device |
Compressed Oxygen (O2) gas | Praxair | Also need pressure regulator and flowmeter | |
Disposable underpad | General stores | ||
Endotracheal (ET) tube 2.0 mm I.D. | Teleflex Medical | 5-10404 | Hudson RCI; Sheridan Uncuffed |
Fluorescent Dissecting Microscope | Leica | MDG41 | |
Heating pad | General stores | ||
Isoflurane | Pharmacy | ||
Isoflurane F/Air Filter Canister | Vetamac Anesthesia | SKU VAD020 | |
Isoflurane regulator (vaporizer) | Vetamac Anesthesia | ||
Laryngoscope traditional set | DarvallVet | #8070 | 4" blade used for delivery |
Leur locking syringe (3 ml) | General stores | ||
Lubricating jelly | General stores | ||
Microsprayer | PennCentury | Aerosolizing catheter; No longer available | |
Pressurized aerosolizing catheter | Trudell Medical Corporation | Aeroprobe; No longer available | |
Pulse oximeter | Pacific Medical Supply | UQNE4600 | |
SpO2 sensor band | Hospital stores | ||
Stylet | Hospital stores | 5 Fr (1.7 mm O.D.) | |
Thermometer (Digital) | General stores | ||
Veterinary anesthesia mask | Hospital stores | ||
Viral vectors | University of Iowa Viral Vector Core | Adenoviral vector; fee for service |
Request permission to reuse the text or figures of this JoVE article
Request PermissionExplore More Articles
This article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved